Morris Jeffrey Allen 13D and 13G filings for Provectus Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-14 7:23 pm Purchase | 2024-08-12 | 13G | Provectus Biopharmaceuticals, Inc. PVCT | Morris Jeffrey Allen | 61,100,610 11.300% | 61,100,610 (New Position) | Filing |